Age, Biography and Wiki

Gareth Sanger was born on 1953 in United Kingdom, is a Gareth J. Sanger is British pharmacologist British pharmacologist. Discover Gareth Sanger's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 71 years old?

Popular As N/A
Occupation N/A
Age 71 years old
Zodiac Sign N/A
Born 1953
Birthday
Birthplace N/A
Nationality United Kingdom

We recommend you to check the complete list of Famous People born on . He is a member of famous with the age 71 years old group.

Gareth Sanger Height, Weight & Measurements

At 71 years old, Gareth Sanger height not available right now. We will update Gareth Sanger's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Gareth Sanger Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Gareth Sanger worth at the age of 71 years old? Gareth Sanger’s income source is mostly from being a successful . He is from United Kingdom. We have estimated Gareth Sanger's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Gareth Sanger Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia Gareth Sanger Wikipedia
Imdb

Timeline

1953

Gareth J. Sanger (born 1953) is a British pharmacologist.

1977

Sanger was a research fellow at King's College Hospital Medical School from 1977 to 1990.

1998

Together with M Tyers he received the 1998 Pharmaceutical Research and Manufacturers of America (PhRMA) "Discoverer's Award" for their research into 5HT3 receptor/antiemesis, which led to the identification and development of the drug Kytril, an antiemetic to treat nausea and vomiting following chemotherapy.

2009

He then spent a period in the pharmacological industry, before being appointed, in 2009, Professor of Neuropharmacology, at Queen Mary University of London.

He has served as editor and reviews editor for the "British Journal of Pharmacology" and as an editorial board member for "Drug Discovery Today".